Efficacy and mechanism of Shugan Jieyu combined with sertraline in alcohol-dependent patients with depression: A randomized clinical study

舍曲林 医学 内科学 萧条(经济学) 抗抑郁药 哈姆德 不利影响 随机对照试验 汉密尔顿抑郁量表 心情 评定量表 重性抑郁障碍 临床试验 临床研究 联合疗法 治疗组和对照组 治疗效果 临床疗效 抑郁症状 安慰剂 入射(几何) 药物治疗 显著性差异
作者
Yan Zhang,Hao-Yu-xing,Juan Yan
出处
期刊:World journal of psychiatry [Baishideng Publishing Group]
卷期号:15 (12)
标识
DOI:10.5498/wjp.v15.i12.111801
摘要

BACKGROUND Proper antidepressant use can improve mood and reduce desire to drink alcohol in alcohol-induced-affective-disorder patients. Shugan Jieyu capsules (SJC) have various impacts on the central nervous system, producing antidepressant effects. Traditional Chinese medicine (including Shugan Jieyu) is highly therapeutic in treating alcohol dependence, with few side-effects. However, research on its combination with Western antidepressants (e.g., sertraline) to improve patients’ depression is insufficient. AIM To evaluate the clinical efficacy and safety of SJC combined with sertraline vs sertraline monotherapy in alcohol-dependent patients with comorbid depression. METHODS We conducted a randomized, double-blind, placebo-controlled trial. Sixty patients (aged 18-65 years) were randomly assigned to two groups (n = 30 per group). Primary outcome: Hamilton Depression Rating Scale (HAMD)-17 changes over 6 weeks. Benzodiazepines were permitted for severe insomnia. RESULTS The HAMD-17 score of the study (vs control) group was lower at treatment weeks 2, 4, and 6 (P < 0.05). Regarding intra-group comparisons, the study group’s HAMD score was significantly lower than that before treatment from week 2 (P < 0.05), while that of the control group was significantly lower than that before treatment from week 4 (P < 0.05). The study and control groups’ total efficacy rates were 90% and 73.3%, respectively, showing a significant difference in efficacy (χ² = 4.812, P = 0.028). No significant difference was observed in adverse reactions’ incidence between the groups at treatment weeks 2, 4, and 6 (P > 0.05). CONCLUSION SJC-sertraline combination therapy accelerates depressive symptom relief (by 2 weeks) and improves response rates (+16.7%) in alcohol-dependent patients, without increasing adverse events. Clinical outcomes suggest potential synergistic mechanisms, though no biomarker analyses were performed.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
今后的应助被pp采纳,获得10
1秒前
1秒前
大胆班发布了新的文献求助30
1秒前
xfcy完成签到,获得积分10
2秒前
3秒前
JamesPei的应助被yaoyao6688采纳,获得10
4秒前
6秒前
Scarlett完成签到,获得积分10
7秒前
小马甲的应助被hhh采纳,获得10
7秒前
8秒前
cocoliu发布了新的文献求助10
8秒前
8秒前
黄艳杰发布了新的文献求助10
8秒前
9秒前
10秒前
esyncoms完成签到,获得积分10
11秒前
Ma发布了新的文献求助10
12秒前
pp发布了新的文献求助10
13秒前
鲸1107发布了新的文献求助10
13秒前
14秒前
科目三的应助被tian采纳,获得10
14秒前
15秒前
FL完成签到 ,获得积分10
15秒前
优雅亦丝完成签到 ,获得积分10
16秒前
络巫琥完成签到,获得积分10
16秒前
魏富林完成签到 ,获得积分10
17秒前
17秒前
17秒前
pp完成签到,获得积分10
19秒前
小马甲的应助被m同学采纳,获得10
19秒前
科研通AI6.2的应助被向雨竹采纳,获得10
20秒前
Spring发布了新的文献求助10
21秒前
小白发布了新的文献求助10
22秒前
22秒前
呆萌的宫苴完成签到 ,获得积分10
22秒前
秋风的应助被奋斗灵凡采纳,获得50
23秒前
楚先森发布了新的文献求助10
23秒前
花边野关注了科研通微信公众号
23秒前
struggle关注了科研通微信公众号
24秒前
bobo完成签到,获得积分10
24秒前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Rosenblum, Global Change Biology 800
Organizational Behavior 510
Arbitrage Theory in Discrete and Continuous Time 500
Production Logging: Theoretical and Interpretive Elements 400
English Longitudinal Study of Ageing: Waves 0-11, 1998-2024 300
2026-2030年中國基因檢測行業市場前瞻與未來投資戰略分析報告 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 有机化学 化学工程 内科学 物理 生物化学 复合材料 催化作用 细胞生物学 人工智能 心理学 无机化学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 7824711
求助须知:如何正确求助?哪些是违规求助? 9351238
关于积分的说明 20560721
捐赠科研通 7417726
什么是DOI,文献DOI怎么找? 3334555
关于科研通互助平台的介绍 2479845
邀请新用户注册赠送积分活动 2354866